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We previously reported that antimycotic agent keto-
conazole suppressed interleukin-4 production in T
cells from patients with atopic dermatitis. We herein
studied if ketoconazole may suppress B cell IgE class
switching. Interleukin-4 plus anti-CD40-induced IgE
secretion was enhanced in peripheral blood surface
IgE± B cells from atopic dermatitis patients com-
pared to those from normal donors, and the secre-
tion was inhibited by ketoconazole. Ketoconazole
suppressed interleukin-4 plus anti-CD40-induced
germline and mature e transcripts in surface IgE±
B cells. Ketoconazole also inhibited interleukin-4
plus anti-CD40-induced activation of germline e pro-
moter in human Burkitt lymphoma Ramos cells.
The regions ±171/±155 bp containing CCAAT/
enhancer-binding protein element and ±155/±109 bp
containing Stat6 and nuclear factor kB elements
were required for the ketoconazole-induced inhib-
ition of the germline e promoter activity.
Ketoconazole inhibited interleukin-4 plus anti-CD40-
induced enhancer activities of CCAAT/enhancer-
binding protein and nuclear factor kB, and those of
composite elements of CCAAT/enhancer-binding
protein/Stat6 or of Stat6/nuclear factor kB, but did
not alter that of Stat6 in Ramos cells. cAMP analog
reversed the inhibitory effects of ketoconazole on
interleukin-4 plus anti-CD40-induced IgE secretion,
germline and mature e transcripts, and e germline
promoter activation. Interleukin-4 plus anti-CD40
increased intracellular cAMP by activating cAMP-
synthesizing adenylate cyclase in surface IgE± B cells,
and the increase was greater in the cells from atopic
dermatitis patients than in those from normal
donors. Ketoconazole suppressed interleukin-4 plus
anti-CD40-induced activation of adenylate cyclase in
surface IgE± B cells. These results suggest that keto-
conazole may suppress interleukin-4 plus anti-CD40-
induced B cell IgE class switching by inhibiting
cAMP signal, and stress its prophylactic effects on
allergic diseases. Key words: cAMP/C/EBP/nuclear fac-
tor kB. J Invest Dermatol 119:590±599, 2002
I
t has recently been reported that systemic and/or topical
treatment with an antimycotic drug, ketoconazole (KC), is
effective for patients with atopic dermatitis (AD)
(Clemmensen and Hjorth, 1983; Back et al, 1995; Broberg
and Faergemann, 1995). This is partly caused by the
fungicidal or fungistatic effects of KC (Agut et al, 1992; Elewski,
1993) as skin-localized fungi such as Malassezia furfur may act as
allergens for IgE-mediated allergic responses in AD (Tengvall
Linder et al, 1996). Direct immunomodulatory effects, however,
nonrelated to fungi, appeared to mediate the therapeutic ef®cacy of
KC on AD, such as the inhibition of the leukotriene synthesis in
polymorphonuclear leukocytes (Bettens et al, 1986), or the
inhibition of reactive radical nitric oxide production in macro-
phages (Baroni et al, 1999).
AD is characterized by abnormally increased IgE production
(Leung, 1995). The allergen-induced ligation of IgE on the surface
of mast cells induces the release of chemical mediators, such as
leukotrienes, histamine, or prostaglandins, and causes immediate
hypersensitivity reaction, which is followed by a late phase
in¯ammatory reaction involving T cells or eosinophils, leading to
the development of atopic eczema (Leung, 1995; Werfel et al,
1995). It is thus a key therapeutic target for AD to prevent B cell
isotype switching to IgE. The B cell IgE switch requires soluble
factors such as interleukin-4 (IL-4) and a T-cell-contact-dependent
signal such as the stimulation of CD40 molecules (Worm and
Henz, 1997). IL-4 ®rstly induces transcription from the germline
promoter located upstream of the gene segments encoding
unrearranged IgE e-heavy chain constant region (Ce). This results
in the production of untranslatable transcripts containing IgE e-
heavy chain germline exon (Ie) and Ce sequences and also makes
the switch region accessible to the putative recombinase. In the
process of switch recombination, Ie is deleted and the Ce gene is
positioned directly downstream of the variable region genes (V(D)J
genes) encoding antigen speci®city (Worm and Henz, 1997). The
switch recombination induced by IL-4 is potentiated by the
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interaction of CD40 on B cells with CD40 ligand on activated T
cells (Shapira et al, 1992).
T cells from AD patients predominantly produce T helper 2 type
cytokines enhancing IgE synthesis, such as IL-4, IL-5, or IL-13, in
response to inhalant allergens like house dust mite (Wierenga et al,
1991). The overexpression of T helper 2 type cytokines may
induce B cell IgE class switch in AD patients (Grewe et al, 1998).
We recently found that KC inhibited anti-CD3 plus anti-CD28-
induced IL-4 and IL-5 production in human T cells by inhibiting
the activity of adenylate cyclase (AC), which synthesizes cAMP
(Kanda et al, 2001). This indicates that KC may indirectly suppress
B cell IgE class switch by inhibiting the production of cytokines
inducing this switch. In this study, we examined if KC may directly
suppress IL-4 plus anti-CD40-induced IgE class switching in
preswitch surface IgE± B cells from patients with AD. We further
analyzed if KC may inhibit the IL-4 plus anti-CD40-induced
germline or mature e transcripts and e germline promoter
activation. The involvement of AC and cAMP signal in the effects
of KC was also investigated.
MATERIALS AND METHODS
Patients with AD and normal donors Peripheral blood was taken
from patients with mild to severe AD [®ve men and ®ve women, age
26.4 6 3.7 y (mean 6 SEM)], diagnosed according to the criteria by
Hani®n and Rajka (1980). The patients' serum total IgE value was
2638 6 501 U per ml (mean 6 SEM). Seven out of the 10 patients
were treated with topical corticosteroids of mild to strong rank and no
patients were receiving systemic corticosteroids, antiallergic or
antihistaminic drugs, or desensitization immunotherapy. Blood was also
taken from nonatopic healthy volunteers [®ve men and four women, age
27.1 6 4.0 y (mean 6 SEM)]. The serum total IgE value in the normal
donors was 78 6 12 U per ml. At the time of the investigation, the AD
patients and normal donors did not have active infection by fungi,
viruses, or bacteria, and were not receiving topical or systemic
antimycotic medication. All the patients and controls were informed of
the objectives and methods of this study, and consented to participate.
Reagents Recombinant human IL-4 was purchased from Genzyme
(Cambridge, MA). Anti-CD40 monoclonal antibody was from
Pharmingen (San Diego, CA). Dibutyryl cAMP (Bt2cAMP), dibutyryl
3¢,5¢-cyclic guanosine monophosphate (Bt2cGMP), N-[2-((p-bromo-
cinnamyl)aminoethyl)-5-isoquinolinesulfonamide (H-89), 1-oleoyl-2-
acetyl-sn-glycerol (OAG), and 3-isobutyl-1-methylxanthine were
obtained from Calbiochem (La Jolla, CA). KC was from Janssen
Pharmaceutica (Beerse, Belgium). These agents were dissolved in
dimethylsulfoxide as 100 mM stock solution and were kept in the dark
until used.
Human surface IgE± B cells and B cell lines Peripheral blood
mononuclear cells from AD patients and normal donors were isolated by
centrifugation over Ficoll-Paque (Pharmacia, Uppsala, Sweden), as
described previously (Boyum, 1968), and were allowed to adhere to
plastic dishes for 1 h at 37°C. From the nonadherent cells, CD56- cells
were isolated by negative selection using immunomagnetic beads (Dynal,
Great Neck, NY), as described previously (Gee et al, 1987), and were
incubated with neuraminidase-treated sheep erythrocytes as described
previously (Farrant et al, 1985). From the nonrosette-forming cells,
CD14 and CD3 cells were isolated by immunomagnetic negative
selection and were used as B cells. This B cell population was > 97%
CD19+, and the contamination of CD14+, CD3+, or CD56+ cells
was < 1%. The puri®ed B cells were incubated for 30±45 min on ice
with ¯uorescein-isothiocyanate-labeled goat antihuman IgE antibody
(Cappel, West Chester, PA). Surface IgE± B cells were sorted on a
FACStar Plus ¯ow cytometer (Becton Dickinson, Mountain View, CA)
with single-color ¯uorescence as described previously (Jabara et al, 1990).
Epstein-Barr-virus-negative, surface IgM+ human Burkitt lymphoma
Ramos cells and IgE-producing human myeloma U266 cells were
maintained in RPMI 1640 (Gibco/BRL, Grand Island, NY) supple-
mented with 10% heat-inactivated fetal bovine serum, 5 3 10±5 M of 2-
mercaptoetanol, 100 U per ml penicillin, 100 mg per ml streptomycin,
and 2 mM of L-glutamine.
Measurement of IgE or total Ig secretion One 3 106 of sorted
surface IgE± B cells were preincubated with or without KC at indicated
concentrations for 30 min, and then incubated with 200 U per ml IL-4
and 1 mg per ml anti-CD40 in the presence or absence of KC for
another 14 d in 1 ml per well of RPMI 1640 supplemented with 10%
fetal bovine serum in 24-well plates at 37°C in an atmosphere of 5%
CO2. The activity of IgE or total Ig in the culture supernatants was
measured by sandwich enzyme-linked immunosorbent assay (ELISA) as
described previously (Punt et al, 1994; Coqueret et al, 1997). The
sensitivity of the assay for IgE or total Ig was 0.3 ng per ml or 1 ng per
ml, respectively.
Proliferation assays Surface IgE± B cells were cultured as above in
triplicate in 96-well plates at a density of 5 3 104 cells per well in a ®nal
volume of 200 ml for 5 d. 1 mCi of 3H-thymidine (Amersham, Arlington
Heights, IL) was added to each well during the last 16 h of culture, and
the cells were harvested and 3H-thymidine uptake was measured by
liquid scintillation.
Northern blotting Sorted surface IgE± B cells were incubated under
the conditions indicated, and total cellular RNA was extracted by the
guanidium isothiocyanate method (Ultraspec, Houston, TX). Aliquots of
RNA 2 mg were electrophoresed in a 1% agarose gel and transferred to
nitrocellulose membranes. Blots were hybridized with 32P-labeled probe
that was a BamHI fragment of genomic DNA containing whole Ce
exons (Gauchat et al, 1990). The membranes were exposed to X-ray
®lms (Hyper®lm MP; Amersham) for 17 h at ±80°C. Autoradiograms
were scanned using a Molecular Dynamics computing densitometer
(model 300 A; Molecular Devices, Menlo Park, CA). For standardizing
the amount of applied RNA, the hybridized ®lter was stripped and
rehybridized to 32P-labeled probe that was a HindIII fragment of
genomic DNA encoding human b-actin.
Plasmids, transfection, and luciferase assays A fragment of the
human e germline promoter (±214/+36 relative to the transcriptional
start site) was ampli®ed by polymerase chain reaction as described
previously (Ichiki et al, 1993; Ikizawa and Yanagihara, 2000). The
ampli®ed products were digested with BamHI and HindIII and inserted
into the promoterless ®re¯y luciferase vector, pGL3 basic (Promega,
Madison, WI). Constructs ±155/+36 and ±109/+36 were obtained by
cutting the above vector by TaqI and SmaI, respectively, and re-ligating.
Construct ±171/+36 was obtained by polymerase chain reaction using
upstream primer carrying a XhoI site and was inserted into the basic
vector as XhoI/HindIII fragment as described previously (Albrecht et al,
1994). The deletion was con®rmed by sequence analysis. p4 3 C/EBP-
SV-luc, p4 3 Stat6-SV-luc, p4 3 NF-kB-SV-luc, p3 3 C/EBP/Stat6-
SV-luc, and p3 3 Stat6/NF-kB-SV-luc were constructed by inserting
four copies of the CCAAT enhancer binding protein (C/EBP) sequences
(5¢-GCTGTTGCTCAATCGAC-3¢), Stat6 sequences (5¢-AATCGACT-
TCCCAAGAACAG-3¢), or nuclear factor kB (NF-kB) sequences (5¢-
AAGGGAACTTCCAA-3¢), or three copies of the sequences containing
C/EBP and Stat6 elements on germline e promoter (±167/±138) or of
the sequences containing Stat6 and NF-kB elements on germline e
promoter (±155/±115), respectively, in front of minimal SV40 promoter
upstream of ®re¯y luciferase reporter as described previously (Delphin
and Stavnezer, 1995; Pesu et al, 2000). 1 3 107 of B lymphoma Ramos
cells were transiently transfected with 10 mg ®ler¯y luciferase construct
and 6 mg control plasmid Rous sarcoma virus-b-galactosidase by
treatment with 0.5 mg per ml DEAE-dextran (Pharmacia, Uppsala,
Sweden) for 30 min at 37°C. Each transfection was performed in
triplicate. After transfection, the cells were split into aliquots and cultured
in the presence or absence of IL-4 (200 U per ml) and anti-CD40 (1 mg
per ml). After 48 h, cell extracts were prepared, and luciferase activities
were quanti®ed using the luciferase assay system (Promega) according to
the manufacturer's instruction. The same cell extracts were assayed for b-
galactosidase activity using chemiluminescent Galacto-Light kit (Tropix,
Bedford, MA). All readings were taken using a Lumat 9501 luminometer
(Berthold, Wildbach, Germany). The results obtained in each
transfection were normalized for b-galactosidase activity and expressed as
relative luciferase activity.
Measurement of cAMP amount B cells were cultured under the
indicated conditions, and were harvested and lyzed with ethanol. The
cell lysates were centrifuged and the supernatants were dried under
vacuum. The dried samples were dissolved in acetate buffer (pH 5.8),
and cellular cAMP contents were measured with an ELISA kit
(Amersham) according to the manufacturer's instruction. The sensitivity
of the assay was 12 fmol per assay well. The cellular cAMP level was
presented as pmol per 106 cells.
Measurement of cyclic nucleotide phosphodiesterase (PDE)
activity B cells were cultured under the indicated conditions, and
were lyzed in buffer containing 20 mM Tris±HCl (pH 7.4), 1 mM
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ethylenediamine tetraacetic acid, 1 mg per ml aprotinin, 1 mg per ml
pepstatin, 1 mg per ml leupeptin, 15 mM benzamidine, and 3.75 mM b-
mercaptoethanol. PDE activity of the cell lysate was assayed as described
previously (Robicsek et al, 1991) using 1 mM [2,8±3H] cAMP (30 Ci
per mmol) (Amersham) as a substrate. The assays were performed in
40 mM Tris±HCl (®nal pH 8.0), 10 mM MgCl2 at 37°C for 10 min,
and PDE activity was presented as pmol cAMP hydrolyzed per min per
mg protein.
Measurement of AC activity The B cell lysate was centrifuged at
23,600g for 10 min. The pellet was used as a particulate fraction for AC
assays as described previously (Salomon et al, 1974; Choi et al, 1992).
The AC activity of the particulate fraction was measured at 37°C for
10 min in 20 mM Tris±HCl (pH 7.4), 1 mM [a-32P] ATP (30 Ci per
mmol) (Amersham), 1 mM [3H] cAMP, 1 mM 3-isobutyl-1-
methylxanthine, 5 mM MgCl2, 0.2 mM ethyleneglycol-bis(b-aminoethyl
ether)-N,N,N¢,N¢-tetraacetic acid, 20 mM creatine phosphate, and 100
units per ml creatine phosphokinase. AC activity was presented as pmol
cAMP formed per min per mg protein.
Assays of cAMP-dependent protein kinase (protein kinase A,
PKA) The B cell lysate was assayed for the activity of PKA using an
ELISA kit (Medical and Biological Laboratories, Nagoya, Japan) by
examining the phosphorylation of plate-bound peptide substrate in the
presence or absence of 2 mM cAMP for 10 min at room temperature.
The plates were sequentially incubated with biotinylated antibody against
the phosphorylated substrate, peroxidase-conjugated streptavidin, and o-
phenylenediamine, and then the reaction was stopped, and optical
density at 492 nm was read. The PKA activity was expressed as an
activity ratio, which is de®ned as the optical density in the absence of
exogenous cAMP divided by that in the presence of cAMP.
Statistical analyses Student's t test was used for the comparison of
mean amounts in AD and normal groups. One-way analysis of variance
with Dunnet's multiple comparison test was used for the data in
Fig 1(a). Paired t test was used for the data in Fig 1(b). One-way
analysis of variance with Scheffe's multiple comparison test was used for
the data in Figs 5 and 6. Spearman's correlation coef®cient was
determined for the data in Fig 7. A value of p < 0.05 was considered
signi®cant.
RESULTS
The effects of KC on IL-4 plus anti-CD40-induced IgE
secretion in surface IgE± B cells from AD patients and
normal donors First, the effects of KC were examined on IL-4
plus anti-CD40-induced secretion of IgE by surface IgE± B cells
from AD patients and normal donors. The IL-4 plus anti-CD40-
induced IgE secretion was signi®cantly higher in AD patients
(mean 6 SEM 85.5 6 9.8 ng per ml, n = 10) than that in normal
donors (30.6 6 4.6 ng per ml, n = 9; p < 0.01 by Student's t test).
The enhanced IgE secretion in AD patients did not appear to be
due to contamination of surface IgE+ B cells as no surface IgE+
cells were detectable in the sorted surface IgE± population upon
Figure 1. The effects of KC on IL-4 plus anti-CD40-induced IgE
or total Ig secretion and proliferation in surface IgE± B cells from
AD patients and normal donors. (a)The surface IgE± B cells from an
AD patient or a normal donor were preincubated for 30 min with
medium alone or with medium containing KC at indicated doses, and
then incubated with 200 U per ml IL-4 plus 1 mg per ml anti-CD40 in
the presence or absence of KC for 14 d. The culture supernatants were
assayed for IgE by ELISA. Values are the mean 6 SD of triplicate
cultures. *p < 0.05 versus control cultures with IL-4 plus anti-CD40
without KC, by one-way analysis of variance with Dunnet's multiple
comparison test. The data shown in the ®gure are representative of ®ve
separate experiments using surface IgE± B cells from ®ve different AD
patients and ®ve different normal donors. (b)The surface IgE± B cells
were cultured as described above with IL-4 plus anti-CD40 in the
presence or absence of KC 1 mM, and total Ig secretion was assessed
after 14 d whereas 3H-thymidine uptake was analyzed after 5 d. The data
are mean 6 SEM (n = 10 for AD patients; n = 9 for normal donors).
The mean 6 SEM of background values with medium alone in AD
patients versus normal donors was as follows: total Ig, 16.2 6 4.8 ng per
ml versus 15.8 6 4.9 ng per ml; 1023 6 302 cpm versus 1131 6 345
cpm, respectively. There were no signi®cant differences between AD
patients and normal donors in total Ig secretion or 3H-thymidine uptake
of background and of culture with IL-4 plus anti-CD40 alone (p > 0.1
by Student's t test).
Figure 2.The effects of KC on IL-4 and/or anti-CD40-induced
germline and mature e transcripts in surface IgE± B cells from an
AD patient. The surface IgE± B cells from an AD patient were
preincubated for 30 min with medium alone or with medium containing
KC at 1 mM, and then incubated with 200 U per ml IL-4 and/or 1 mg
per ml anti-CD40 in the presence or absence of KC for 8 d. RNA was
isolated and hybridized with a probe complementary to Ce or b-actin.
The data shown in the ®gure are representative of ®ve separate
experiments using B cells from ®ve different AD patients. RNA was also
isolated from IgE-producing myeloma U266 cells after 8 d of culture in
the presence or absence of KC 1 mM and was hybridized with the same
probes as a control.
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reanalysis by ¯ow cytometry (data not shown). Furthermore,
medium alone, IL-4 alone, or anti-CD40 alone did not induce
detectable IgE secretion in surface IgE± B cells from either AD
patients or normal donors. KC dose-dependently reduced the IL-4
plus anti-CD40-induced IgE secretion: 65.1% inhibition versus
controls in AD patients and 75.2% inhibition in normal donors at
1 mM (Fig 1a). Thus KC inhibited IL-4 plus anti-CD40-induced
IgE secretion in AD patients' and normal donors' surface IgE±
B cells. As 1 mM appeared to be the optimal concentration for the
inhibitory effects of KC, this concentration was used in the further
experiments. In parallel, we examined the effects of KC on total Ig
secretion and proliferation. KC did not alter IL-4 plus anti-CD40-
induced total Ig secretion or 3H-thymidine uptake in surface IgE±
B cells from either AD patients or normal donors (Fig 1b). Thus
the inhibitory effect of KC on these cells was speci®c to IgE
secretion. We next examined if KC may inhibit germline or mature
e transcripts.
The effects of KC on IL-4 plus anti-CD40-induced germline
and mature e transcripts in surface IgE± B cells Northern
blots using Ce probe revealed two e mRNA species, 2.2 kb and
1.7 kb (Fig 2). The 2.2 kb e mRNA was the same size as that from
IgE-secreting myeloma U266, suggesting that the 2.2 kb mRNA
may be mature productive e transcript and the 1.7 kb mRNA may
be the germline e transcript, which was consistent with the
previous studies (Gauchat et al, 1990). IL-4 alone induced germline
Ce transcript whereas anti-CD40 alone did not, and IL-4 plus anti-
CD40 resulted in further increased germline Ce transcript and also
induced mature Ce transcript in surface IgE± B cells from AD
patients. KC reduced IL-4 or IL-4 plus anti-CD40-induced
germline Ce mRNA level by 62% or by 67% versus controls,
respectively, as examined by the intensity normalized for that of b-
actin. KC also reduced IL-4 plus anti-CD40-induced mature Ce
mRNA level by 66%. Similar results were obtained in surface IgE±
B cells from normal donors (data not shown). In contrast, KC did
not reduce mature e mRNA level in U266 cells. Thus KC reduced
the germline and mature e mRNA levels in surface IgE± B cells,
but did not inhibit mature e mRNA expression in myeloma cells,
which have completed IgE class switch.
The effects of KC on IL-4 or IL-4 plus anti-CD40-induced
activation of germline e promoter We then assessed if KC
may also inhibit germline e promoter activity in Epstein-Barr-
virus-negative Burkitt lymphoma Ramos cells secreting IgM but
not IgE. Ramos cells were transiently transfected with the luciferase
reporter construct driven by germline e promoter (±214/+36), and
subsequently stimulated with IL-4 and/or anti-CD40. The attempt
to transfect peripheral blood B cells was unsuccessful (data not
shown). As shown in the uppermost ®ve columns of Fig 3, IL-4
alone increased e germline promoter (±214/+36) activity, as
examined by relative luciferase activity, and anti-CD40 further
potentiated the IL-4-induced promoter activation though anti-
CD40 alone only modestly increased the promoter activity. KC
suppressed the germline e promoter activation induced by IL-4
alone or together with anti-CD40. According to the percentage
inhibition, the promoter activation by IL-4 alone may be the main
target of KC-induced inhibition whereas additional inhibition of
the combined response to IL-4 plus anti-CD40 was negligible.
Thus KC appeared to inhibit germline or mature e transcripts by
mainly inhibiting IL-4-induced germline e promoter activation,
though it is also possible that KC may inhibit the switch
recombination to IgE following germline e transcription.
To determine the sequences on germline e promoter involved in
the KC-induced inhibition, we transfected Ramos cells with
serially 5¢-deleted promoters linked to luciferase reporter, and
compared the effects of KC on promoter induction by IL-4 alone
or together with anti-CD40. The activity of ±171/+36 promoter
was increased by IL-4, anti-CD40, or their combination to extents
comparable to those in ±214/+36 promoter, and the magnitude of
the inhibition by KC on the inducibility was similar to that in
Figure 3. IL-4 and/or anti-CD40-induced
activation and KC-induced inhibition of
germline e promoter in Ramos cells. Ramos
cells were transiently transfected with luciferase
reporter plasmids driven by serially 5¢-deleted e
germline promoters together with b-galactosidase
vector. The cells were split into aliquots and
preincubated with KC (1 mM) for 30 min, and
then incubated with medium alone, IL-4 (200 U
per ml), anti-CD40 (1 mg per ml), or IL-4 plus
anti-CD40, in the presence or absence of KC for
48 h. The cells were harvested, and luciferase
activities of the cell lysates were assayed and
standardized for b-galactosidase activities. The
results are shown as fold induction above the
relative luciferase activity in unstimulated cells
incubated with medium alone. The data represent
the mean 6 SEM of three separate experiments.
Percent inhibition by KC on IL-4- or IL-4 plus
anti-CD40-induced promoter activation is
depicted to the far left. The putative transcription
factor binding sites in the critical region of the e
germline promoter are shown at the top.
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±214/+36 promoter. After deletion of the ±174/±155 region, a
signi®cant proportion (54% or 62%, respectively) of the inducibility
by IL-4 or IL-4 plus anti-CD40 was lost, and KC-induced
inhibition on the inducibility greatly decreased. A further deletion
of ±155/±109 completely abolished the residual inducibility and
inhibition. These results suggest that the ±174/±155 region may
mainly confer the germline e promoter induction by IL-4 or IL-4
plus anti-CD40 and may be required for KC-mediated inhibition
of the induction. The ±155/±109 region may also be involved in
the inducibility and inhibition.
The ±174/±155 region contains the binding site for transcription
factor C/EBP (±163/±155), and the ±155/±109 region contains
Stat6 (±149/±142) and NF-kB (±129/±120) sites (Fig 3, top;
Thienes et al, 1997). Thus these three elements in the region
±167/±115 (Fig 3, top) may confer the promoter induction by IL-4
alone or together with anti-CD40, and may be required for the
inhibition by KC. It is reported that C/EBP and Stat6 cooperate to
activate germline e transcription in response to IL-4 (Mikita et al,
1998; Pesu et al, 2000). Anti-CD40 and IL-4 enhance the
transcriptional activity of NF-kB (Berberich et al, 1994;
Yanagihara et al, 1996). The transcriptional cooperation of Stat6
and NF-kB is also reported (Stutz and Woistetschlager, 1999;
Monticelli and Vercelli, 2001). We thus examined if KC may
inhibit the IL-4 or IL-4 plus anti-CD40-induced enhancer
activities C/EBP, Stat6, NF-kB, or composite elements C/EBP/
Stat6, Stat6/NF-kB. IL-4 alone or together with anti-CD40
increased the enhancer activity of C/EBP, Stat6, and NF-kB, and
composite elements of C/EBP/Stat6 and Stat6/NF-kB, and the
increases were inhibited by KC except for IL-4-induced Stat6
enhancer activity (Fig 4). These results suggest that KC may inhibit
the IL-4 or IL-4 plus anti-CD40-induced enhancer activities of C/
EBP and NF-kB, and also the cooperativity of C/EBP and Stat6 or
of Stat6 and NF-kB, though KC may not directly inhibit the
enhancer activity of Stat6. The results also indicate that all the three
elements C/EBP, Stat6, and NF-kB in the region ±167/±115 may
be involved in the IL-4 or IL-4 plus anti-CD40-induced germline e
promoter activation and in the inhibition by KC of the induction.
According to the percentage inhibition, the enhancer activities
induced by IL-4 alone appeared to be the main target of KC-
induced inhibition.
CAMP-induced reversal from the KC-induced inhibition on
B cell isotype switching to IgE We have recently found that
KC suppresses anti-CD3/CD28-induced IL-4 and IL-5 production
in human T cells by suppressing cAMP signal (Kanda et al, 2001).
We thus examined if the KC-induced inhibition of B cell IgE class
switching may also involve cAMP, by using cAMP analog
Bt2cAMP, which activates cAMP-dependent PKA. Bt2cAMP
counteracted the KC-induced inhibition of IgE secretion
(Fig 5a) and germline and mature e transcripts (Fig 5e) in IL-4
plus anti-CD40-stimulated surface IgE± B cells from AD patients
and normal donors (data not shown). Bt2cAMP also reversed the
KC-induced inhibition of germline e transcript by IL-4 alone
(Fig 5e). Bt2cAMP also counteracted the KC-induced inhibition of
germline e promoter activity (Fig 5b) and of C/EBP and NF-kB
enhancer activities (Fig 5c, d) in IL-4 plus anti-CD40-stimulated
Ramos cells. These results indicate that the cAMP/PKA-dependent
signaling pathway may be involved in the KC-mediated inhibition
of IgE class switching. On the other hand, cGMP analog Bt2cGMP
or PKC activator OAG did not counteract the KC-induced
inhibition on IgE secretion, germline and mature e transcripts,
germline e promoter activity, and C/EBP and NF-kB enhancer
activities. The speci®c PKA inhibitor H-89 reduced IL-4 plus anti-
CD40-induced IgE secretion by 71% (Fig 5a) and suppressed
germline and mature e transcripts (Fig 5e) in surface IgE± B cells
from AD patients. H-89 also reduced the IL-4 plus anti-CD40-
induced increase of germline e promoter activity by 75% (Fig 5b),
of C/EBP enhancer activity by 60% (Fig 5c), and of NF-kB
enhancer activity by 67% (Fig 5d) in Ramos cells. In contrast, H-
89 did not inhibit Stat6 enhancer activity induced by IL-4 or IL-4
plus anti-CD40 (data not shown). These results suggest that the
cAMP/PKA signaling pathway may be required for IL-4 plus anti-
CD40-induced IgE secretion, germline and mature e transcripts,
germline e promoter activity, and C/EBP and NF-kB enhancer
activities, but not that of Stat6. In the presence of H-89, KC did
not further suppress the IL-4 plus anti-CD40-induced IgE
secretion, germline and mature e transcripts, and germline e
promoter and C/EBP and NF-kB enhancer activities. This
con®rms that the cAMP/PKA pathway may be the main target
for the KC-induced inhibition of IgE class switching. These results
suggest that the KC-induced inhibition of IgE class switching may
be attributable to inhibition of the cAMP/PKA signaling pathway.
We then examined whether KC may alter cAMP level in IL-4 plus
anti-CD40-stimulated surface IgE± B cells.
The effects of KC on cAMP signal in IL-4 plus anti-CD40-
stimulated surface IgE± B cells At 10 min of incubation, IL-4
alone, anti-CD40 alone, or IL-4 plus anti-CD40 increased the
Figure 4.IL-4 and/or anti-CD40-induced
activation and KC-induced inhibition on the
enhancer activities of C/EBP, Stat6, NF-kB,
or their composite elements. Ramos cells were
transiently transfected with luciferase reporter
plasmids driven by C/EBP, Stat6, NF-kB
element, or composite elements of C/EBP/Stat6
or of Stat6/NF-kB, or enhancerless reporter
plasmid together with b-galactosidase vector. The
cells were split into aliquots and preincubated
with KC (1 mM) for 30 min, and then incubated
with medium alone (control), IL-4 (200 U per
ml), anti-CD40 (1 mg per ml), or IL-4 plus anti-
CD40 in the presence or absence of KC for 48 h.
The cells were harvested, and luciferase activities
of the cell lysates were assayed. The results are
shown as relative luciferase activities normalized
for b-galactosidase activities, and represent mean
6 SEM of three separate experiments. Percent
inhibition by KC on IL-4- or IL-4 plus anti-
CD40-induced increase of enhancer activity is
depicted to the far left.
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cAMP level in AD patients' surface IgE± B cells 3.8-fold, 3.1-fold,
and 6.1-fold of controls, respectively (Fig 6a, upper half). KC
reduced the IL-4 plus anti-CD40-induced increase of cAMP by
80% in the patients' cells. IL-4 alone, anti-CD40 alone, or IL-4 plus
anti-CD40 increased the cAMP level in normal donors' surface
IgE± B cells 1.8-fold, 1.5-fold, or 2.5-fold of controls, respectively,
and KC reduced the IL-4 plus anti-CD40-induced increase of
cAMP by 95% (Fig 6a, lower half). Though the basal cAMP level
was not different between AD patients' (mean 6 SEM
1.80 6 0.51 pmol per 106 cells; n = 10) and normal donors'
surface IgE± B cells (2.01 6 0.53 pmol per 106 cells; n = 9; p
> 0.10 by Student's t test), the cAMP level in IL-4 plus anti-CD40-
stimulated cells was higher in AD patients (11.2 6 2.1 pmol per
106 cells) than in normal donors (5.0 6 1.0 pmol per 106 cells, p
< 0.01, by Student's t test). In both AD patients and normal donors,
the cAMP level in IL-4 plus anti-CD40-stimulated surface IgE±
B cells correlated with the IL-4 plus anti-CD40-induced IgE
secretion (Fig 7). These results indicate that the IL-4 plus anti-
CD40-induced increase of cAMP may be responsible for IgE
secretion. The IL-4 plus anti-CD40 enhanced PKA activity in AD
patients' and normal donors' surface IgE± B cells (Fig 6b). Though
the constitutive PKA activity in surface IgE± B cells was not
different between AD patients (0.20 6 0.03) and normal donors
(0.21 6 0.04; p > 0.1, by Student's t test), PKA activity in IL-4
plus anti-CD40-stimulated cells was higher in AD patients
(0.75 6 0.08) than in normal donors (0.45 6 0.05; p < 0.01 by
Student's t test), which paralleled the results in cAMP level. KC
suppressed the IL-4 plus anti-CD40-induced activation of PKA in
AD patients' and normal donors' surface IgE± B cells (Fig 6b) in
parallel with the reduction of cAMP (Fig 6a). IL-4 alone, anti-
CD40 alone, and IL-4 plus anti-CD40 increased AC activity of AD
patients' surface IgE± B cells 4.3-fold, 3.8-fold, and 7.0-fold of
controls, respectively, and increased that of normal donors' surface
IgE± B cells 2.7-fold, 2.0-fold, and 4.0-fold of controls, respectively
(Fig 6c). Though the basal AC activity of surface IgE± B cells was
not different between AD patients (30.5 6 6.1 pmol per min per
mg protein) and normal donors (31.3 6 6.2 pmol per min per mg
protein; p > 0.10 by Student's t test), the AC activity in IL-4 plus
anti-CD40-stimulated cells was signi®cantly higher in AD patients
(210.3 6 31.2 pmol per min per mg protein) than in normal
donors (121.1 6 19.1 pmol per min per mg protein; p < 0.05 by
Student's t test). KC reduced the IL-4 plus anti-CD40-induced
Figure 5. The reversal by cAMP analog
Bt2cAMP of KC-induced inhibition of IgE
secretion, germline e promoter activity,
enhancer activities of C/EBP and NF-kB,
and germline and mature e transcripts.
(a)Surface IgE± B cells from ®ve different AD
patients were preincubated for 30 min with
medium alone or with Bt2cAMP 100 mM,
Bt2cGMP 100 mM, OAG 100 ng per ml, or H-89
0.1 mM in the presence or absence of KC 1 mM,
and then incubated with IL-4 200 U per ml plus
anti-CD40 1 mg per ml for 14 d in the presence
or absence of the above-mentioned agents. IgE
secretion was analyzed by ELISA. The results are
shown as mean 6 SEM (n = 5). ND, not
detectable. (b±d) Ramos cells were transiently
transfected with luciferase reporter plasmids driven
by e germline promoter (±171/+36) (b)or C/EBP
element (c)or NF-kB element (d)together with b-
galactosidase vector. The cells were split into
aliquots and preincubated with the indicated
agents as above, and then incubated with IL-4
plus anti-CD40 in the presence or absence of the
respective agents. After 48 h, the cells were
harvested and luciferase activities of the cell lysates
were assayed. The results are shown as relative
luciferase activity normalized for b-galactosidase
activity and represent the mean 6 SEM of three
separate experiments. *p < 0.05 versus cultures
with IL-4 plus anti-CD40 alone, and ²p < 0.05
versus cultures with IL-4 plus anti-CD40 plus KC,
by one-way analysis of variance with Scheffe's
multiple comparison test. (e)Surface IgE± B cells
from an AD patient were incubated under the
indicated conditions for 8 d. RNA was isolated
and hybridized with a probe complementary to
Ce or b-actin. The data shown in the ®gure are
representative of ®ve separate experiments using
B cells from ®ve different AD patients.
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increase of AC activity by 78% and by 94% of controls in AD
patients' and normal donors' surface IgE± B cells, respectively. As
the upregulation of cAMP-hydrolyzing PDE activity also decreases
cAMP level, we analyzed whether KC may enhance the PDE
activity of IL-4 plus anti-CD40-stimulated surface IgE± B cells. IL-
4 plus anti-CD40 enhanced PDE activity of surface IgE± B cells
from AD patients or normal donors moderately, 1.9- or 1.7-fold of
controls, respectively, 10 min after the stimuli, and the PDE
activity was not enhanced but rather slightly reduced by KC
(Fig 6d), indicating that the reduction of cAMP level by KC may
not be caused by the enhancement of PDE activity. In Ramos cells,
IL-4 plus anti-CD40 increased AC and PKA activities and cAMP
level, and the increases were suppressed by KC, but their PDE
activity was not enhanced by KC (data not shown). These results
suggest that KC may suppress the IL-4 plus anti-CD40-induced
activation of AC and thus may suppress the IL-4 plus anti-CD40-
induced cAMP signal in AD patients' and normal donors' surface
IgE± B cells and Ramos cells.
DISCUSSION
In this study, KC suppressed e germline transcription by inhibiting
AC and its product cAMP. KC also inhibits AC in human T cells
(Kanda et al, 2001) and rat anterior pituitary cells (Stalla et al, 1988,
1989). It is known that IL-4 increases cAMP level in B cells (Finney
et al, 1990). The binding of IL-4 to its receptor activates the
receptor-associated src kinase fyn, which phosphorylates and
activates phospholipase Cg1 (Ikizawa et al, 1994). The activated
phospholipase C generates inositol 1,4,5-triphosphate and diacyl-
glycerol; the former induces intracellular Ca2+ signal and the latter
activates PKC (Bihoreau et al, 1991). Ca2+ complexed with
cytosolic calmodulin activates AC (Iyengar, 1993), and PKC
activates AC by phosphorylation (Bihoreau et al, 1991; Iyengar,
1993; Jacobowitz and Iyengar, 1994; Watson et al, 1994). PKC-
mediated phosphorylation also suppresses the inhibitory guanine-
nucleotide-binding protein, which inactivates AC (Chen and
Iyengar, 1993), and induces the stimulatory guanine-nucleotide-
binding protein to activate AC (Bell et al, 1985). The ligation of
CD40 on resting B cells also increases cAMP (Knox et al, 1993;
Kato et al, 1994), possibly via phospholipase C (Ren et al, 1994).
cAMP at least partially conferred the germline e promoter
activation by IL-4 and anti-CD40. KC-mediated inhibition of
cAMP signal led to the suppression of IL-4 or IL-4 plus anti-
CD40-induced e germline transcription. KC did not inhibit mature
Figure 6. IL-4 and/or anti-CD40-induced increase and KC-
induced reduction of the intracellular cAMP level (a), PKA (b),
AC (c), and PDE (d) activities in surface IgE± B cells from AD
patients and normal donors. Surface IgE± B cells from 10 AD
patients and nine normal donors were preincubated with KC 1 mM for
30 min, and then incubated with IL-4 (200 U per ml), anti-CD40 (1 mg
per ml), or IL-4 plus anti-CD40 in the presence or absence of KC for
10 min. Intracellular cAMP level, the activities of PKA and PDE in the
cell lysates, or AC activity in the particulate fraction were analyzed as
described in Materials and Methods. The mean 6 SEM (n = 10) in AD
patients is shown in the upper half of each ®gure and the mean 6 SEM
(n = 9) in normal donors is shown in the lower half. *p < 0.05 versus
values with medium alone, and ²p < 0.05 versus values with IL-4 plus
anti-CD40 alone, by one-way analysis of variance with Scheffe's multiple
comparison test.
Figure 7. Correlation between cAMP level and IgE secretion in
IL-4 plus anti-CD40-stimulated surface IgE± B cells from AD
patients (a) and normal donors (b). Surface IgE± B cells from 10 AD
patients and nine normal donors were incubated with IL-4 (200 U per
ml) plus anti-CD40 (1 mg per ml). The intracellular cAMP level was
analyzed after 10 min whereas IgE secretion was assayed after 14 d. rs =
Spearman's correlation coef®cient.
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e transcript in U266 myeloma cells, however, indicating that cAMP
may not be necessary for mature e transcript in cells that have
completed IgE class switch. Furthermore KC did not inhibit IL-4
plus anti-CD40-induced total Ig secretion or proliferation even in
surface IgE± B cells. This indicates that cAMP may not be
responsible for total Ig secretion or proliferation in these cells.
The cAMP-activated PKA phosphorylates cAMP-responsive
element binding protein (CREB) and promotes its transcriptional
activity through cAMP-responsive element (CRE) on various
genes (Gonzalez and Montminy, 1989). IL-4 plus anti-CD40
induced the CRE-dependent OCA-B gene expression in murine
B cells (Stevens et al, 2000). cAMP also promotes the transcriptional
activity of C/EBPb and NF-kB (Shirakawa et al, 1989; Bomsztyk et
al, 1990; Motomura et al, 1998; Park et al, 1999; Pohnke et al,
1999); PKA induces the synthesis of C/EBPb via CRE on C/
EBPb promoter (Berrier et al, 1998; Niehof et al, 2001), and also
promotes the nuclear translocation of C/EBPb (Metz and Ziff,
1991; Chinery et al, 1997). PKA phosphorylates cytosolic I-kB
associated with NF-kB, which induces the dissociation and nuclear
translocation of the free, activated form of NF-kB (Shirakawa and
Mizel, 1989), and thus induces NF-kB-dependent gene expression
in B cells (Lapointe et al, 1996). Though the IL-4 plus anti-CD40-
responsive region on the germline e promoter does not contain
consensus CRE, this region contains the binding sites for C/EBP,
Stat6, and NF-kB (Delphin and Stavnezer, 1995; Thienes et al,
1997). IL-4- or IL-4 plus anti-CD40-induced transcription
through C/EBP and NF-kB was at least partially mediated by
cAMP. On the other hand, IL-4-induced activation of Stat6 may
not require cAMP signal. The previous studies reported that the
activity of Stat6 may be regulated by serine/threonine kinase
different from PKA or PKC (Pesu et al, 2000). The transcriptional
activators binding to C/EBP, Stat6, and NF-kB sites interact with
one another on e germline promoter and thus synergistically
enhance the transcription (Delphin and Stavnezer, 1995; Iciek et al,
1997; Mikita et al, 1998; Monticelli and Vercelli, 2001). cAMP may
indirectly promote the cooperation of Stat6 with C/EBP or with
NF-kB in the transcription by enhancing the activity of C/EBP
and NF-kB. Such transcriptional cooperation may be indirectly
inhibited by KC via suppression of cAMP.
It is reported that the overexpression of C/EBPb promotes the
transcription through the composite element C/EBP/Stat6 on
human germline e promoter (Shen and Stavnezer, 2001), and
recombinant C/EBPb can bind to the putative C/EBP element on
this promoter (Mikita et al, 1998). The binding of endogenous C/
EBP family proteins has not been reported, however. Thus the
other cAMP-inducible transcription factor(s) may bind to this
element and confer the transcription. As activating transcription
factor/CREB family proteins can bind to C/EBP element (Fawcett
et al, 1999; Zhou and Finch, 1999), these may bind to the putative
C/EBP site on human germline e promoter. This possibility should
be further examined.
In murine germline e promoter, the sequence (5¢-
TTAGTCAAC-3¢, ±120/±112 relative to the transcriptional start
site) upstream of Stat6 site is different from the human sequence,
and this element is bound by activator protein 1 (AP-1) family
proteins, and is thus rede®ned as AP-1 site (Shen and Stavnezer,
2001). AP-1 proteins transactivated murine germline e promoter
but did not transactivate human promoter (Shen and Stavnezer,
2001). When Ramos cells were transfected with luciferase reporter
plasmids containing tandem repeats of AP-1 (5¢-TGCCTTA-
GTCAA-3¢, ±124/±112) or composite element AP-1/Stat6 (5¢-
TGCCTTAGTCAACTTCCCAAGAACAG-3¢, ±124/±99) from
mouse germline e promoter, IL-4 plus anti-CD40-induced
enhancer activities of these elements were not inhibited by KC
(our unpublished observation). This indicates that cAMP may not
be responsible for the AP-1-dependent transcription induced by
IL-4 plus anti-CD40. Though cAMP induces the expression of
AP-1 family c-Fos (Ahn et al, 1998), cAMP-independent protein
kinase(s), such as stress-activated protein kinases (Berberich et al,
1996), may regulate the AP-1-mediated transcription. Thus cAMP
may differently regulate human versus murine germline e transcrip-
tion through the element upstream of Stat6 site, possibly due to the
different DNA-binding speci®cities. On the other hand, the
sequence of NF-kB site (±90/±81) downstream of Stat6 in
mouse germline e promoter is identical with that in human
promoter. KC inhibited the IL-4 plus anti-CD40-induced
enhancer activities of NF-kB (±92/±79) and composite Stat6/
NF-kB (±112/±76) elements from murine germline e promoter, as
examined by reporter assays using Ramos cells (our unpublished
observation). Thus cAMP may be involved in NF-kB-dependent
transcription on murine promoter, similarly to that on human
promoter.
There may possibly be another mechanism for cAMP-induced
germline e transcription; PKA may inhibit the activity of
transcriptional repressor. PKA-mediated phosphorylation may
suppress the binding of putative repressor(s) to the unde®ned
negative regulatory element on the IL-4 plus anti-CD40-inducible
region, and this may promote the germline e transcription. This
mechanism is proposed for IL-4-induced CD25 expression in
human B cell lines (Mckay et al, 2000). cAMP may also promote
the switch recombination that juxtaposes Ce to V(D)J genes,
following germline e transcription. Previous studies reported that
cAMP-elevating agents promoted the expression of recombina-
tion-activating genes RAG1 and RAG2 (Menetski and Gellert,
1990; Casilas et al, 1995). KC may counteract the cAMP-induced
inhibition of transcriptional repressor and/or class switch recombi-
nation. These possibilities should be further examined.
IL-4 plus anti-CD40-induced cAMP signal in surface IgE± B cells
was greater in AD patients than in normal donors (Fig 6), and this
may contribute to the enhanced IgE secretion in the former. This
indicates that AC in surface IgE± B cells from AD patients may be
more sensitive to IL-4 or anti-CD40-induced signals such as
phospholipase C, Ca2+, and/or PKC, compared to normal donors.
This may possibly be due to the difference in AC isoforms between
AD patients and normal donors. PKC stimulates AC types 2 and 7,
and Ca2+/calmodulin stimulates AC types 1 and 3, whereas Ca2+
inhibits AC types 5 and 6 (Iyengar, 1993). Thus the amounts of AC
types 2 and 7 and/or 1 and 3 may be increased and/or those of AC
types 5 and 6 may be reduced in AD patients' surface IgE± B cells.
Another possible reason is that IL-4 or anti-CD40 may more
potently activate phospholipase C in AD patients' surface IgE±
B cells, which may lead to the higher levels of PKC activation and/
or Ca2+ signal, and may result in the greater level of AC activation.
Alternatively, some surface IgE± B cells in AD patients may have
already started IgE class switch in vivo, and AC of these cells may
have higher responsiveness to IL-4 or anti-CD40. These possibil-
ities should be further examined.
The stimulation of CD3 activates AC via phospholipase C in T
cells (Bihoreau et al, 1991). In our previous study, anti-CD3/
CD28-induced cAMP signal was greater in AD patients' T cells
compared to normal donors, and this correlated with the enhanced
IL-4 production in the former (Kanda et al, 2001). Thus in AD
patients the responsiveness of AC appears to be enhanced in both
surface IgE± B cells and T cells, which may lead to the high
potentiality for IgE class switch in the former and to the increased
production of IgE-class-switch-inducing IL-4 in the latter. The
enhanced responsiveness of AC in both cell types may thus totally
induce the abnormally enhanced IgE synthesis in AD patients.
Our results indicate that KC may prevent IgE class switch in
surface IgE± B cells and thus prevent the initiation of IgE-mediated
allergic reactions. The responsiveness to KC may vary with B cell
activation status and/or B cell sources, however. Knox et al (1993)
reported that anti-CD40 decreased cAMP level in human surface
CD39± IgD± B cells from tonsillar germinal centers though it
increased cAMP in high density resting B cells. Thus cAMP signal
may be distinctly regulated by anti-CD40 or IL-4 in different B cell
subsets, and thus its contribution to IgE class switch may differ with
the different subsets. We should further examine the involvement
of cAMP in IgE class switch and the effects of KC on the switch in
different B cell subsets. We should also examine if KC may suppress
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B cell IgE class switch induced by stimuli other than IL-4 or anti-
CD40. In particular IL-13 increases intracellular cAMP as well as
IL-4 (Sozzani et al, 1995). We are now studying the effects of KC
on IL-13 plus anti-CD40-induced IgE class switching in human
surface IgE± B cells.
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